CI
$298.28-2.45%
as of close, Oct 27, 2026
☾ AH $298.28 -2.45%
CI — The Cigna Group price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
150.0200.0250.0300.0350.0020.0M$298.28—20162019202120242026
2026-10-27
Price$298.28
MA20$283.72
MA50$282.95
Vol6.5M
Key stats#
Price data
- Price
- $298.28
- YTD price return
- +8.37%
- YTD total return
- +10.21%
- Next earnings
- Nov 5, 2026 · Before open
- Market cap
- 78.8B
- Enterprise value
- 103.8B
- Shares outstanding
- 264.2M
- 52W low
- $239.51
- 52W high
- $316.27
- From 52W high
- -5.69%
- From 52W low
- +24.54%
- 52W range
- 77%
- Beta
- 0.31
Volume
- Rel volume
- 0.85×
- 30D volume
- 1.6M
- 30D $ vol
- 455.2M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$6.3M
- Insider net 1Y
- −$66.8M
Form 4 transactions by trade date, as filed; latest on file 2026-09-03.
Fundamentals
- Sales (ttm)
- 282.4B
- Sales/share
- $1,068.66
- EPS (ttm)
- $24.18
- Book value/share
- $161.29
- Net margin
- 2.27%
- ROE
- 15.05%
- ROA
- 4.08%
- Debt / equity
- 0.68×
- Current ratio
- 0.85
Growth (CAGR, ttm) · 10Y
- Sales
- +7.78%+14.90%+11.11%+21.97%
- Net income
- +27.88%-1.57%-4.76%+12.48%
- FCF
- +160.35%+33.28%n/an/a
- Shares
- -1.01%-3.71%-4.92%+0.30%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +32.59%+3.55%+1.03%+12.11%
- Sales/share
- +8.87%+19.33%+16.86%+21.61%
- FCF/share
- +165.96%+17.81%n/an/a
- Book value/share
- +7.07%+1.65%+2.41%+11.98%
- Dividend/share
- +5.50%+9.32%+23.70%+65.44%
- Price
- -3.53%-0.55%+6.93%+9.19%
- Total return
- -1.34%+1.40%+8.93%+10.36%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 12.3×
- P/OI (ttm)
- 7.9×
- Fwd P/E
- 9.2×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- 1.8×
- EV/EBITDA (fy)
- 8.2×
- EV/Sales (ttm)
- 0.4×
- Dividend yield (fwd)
- 2.09%
- Dividend yield (ttm)
- 2.08%
- Dividend/share (fwd)
- $6.24
- Buyback yield (realized, 1y)
- 1.01%
- Shareholder yield (realized, 1y)
- 2.85%
- Buyback yield (cash, ttm)
- 1.35%
- Shareholder yield (cash, ttm)
- 3.41%
Vs own 10Y history
- P/E
- 23rd
- P/OI
- 12th
- P/S
- 9th
- P/B
- 50th
- P/FCF
- 1st
Bar = where today’s multiple sits in CI’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-2.45%
5D
-2.71%
1M
+9.66%
3M
+2.49%
YTD
+8.37%
1Y
-3.53%
5Y
+39.78%
Recent filings#
- Jul 30Earnings · Earnings release — EPS $7.78 vs $7.58 est. (+2.6%); revenue $71.67B (+7% y/y) 3.0%
Financial statements
Open full CI financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
